Healius (HLS) AGM 2024 summary

Opening remarks and agenda

• Board members and executive team introduced; agenda included re-elections, remuneration report, and constitutional changes.

• Polls for all items of business declared open at the start of the meeting.

Financial performance review

• Pathology volumes increased by 4.5% and revenues by 5.9% year-to-date; EBIT for 1H25 expected to be in line with 1H24.

• Lumus Imaging exam volumes up 16% and revenue up 11% year-to-date; EBIT expected to rise by 40% in 1H25.

• Agilex reported 20.8% revenue growth and a 102.3% increase in EBITDA, with EBIT nearly tripling to AUD 5.1 million.

• Balance sheet pressures expected to ease following the sale of Lumus Imaging, with proceeds to be used for debt reduction and special dividends.

Board and executive committee updates

• Paul Anderson appointed CEO in March 2024; Steve Humphries became CFO.

• Five new members joined the leadership team, focusing on improved results.

• Two new directors joined in FY24; ongoing board renewal planned.

• Ravi Jeyaraj resigned from the board in August 2024 due to an overseas role.